Association of Plasma Circulatory Markers, Chlamydia pneumoniae, and High Sensitive C-Reactive Protein in Coronary Artery Disease Patients of India

Table 3

Evaluation of plasma circulatory markers in Chlamydia pneumoniae IgA positive coronary artery disease patients and controls.

Plasma circulatory markers	CAD patients		P-value	Controls		P-value
	IgA (+ve) (𝑛=155)	IgA (−ve) (𝑛=37)		IgA (+ve) (𝑛=77)	IgA (−ve) (𝑛=115)
	mean ± SD	mean ± SD		mean ± SD	mean ± SD
IL-4 (pg/mL)	1.31±0.13	1.17±0.12	.007*	1.06±0.08	0.92±0.08	<.001*
IL-8 (pg/mL)	3.41±0.31	2.76±0.26	.015*	2.46±0.23	2.31±0.21	.444
IL-10 (pg/mL)	1.82±0.11	1.86±0.11	<.001*	1.95±0.14	1.96±0.15	.879
IL-13 (pg/mL)	4.84±0.41	4.70±0.42	.918	4.34±0.36	4.20±0.40	.773
IFN-𝜆 (pg/mL)	1.57±0.14	1.65±0.12	<.001*	1.54±0.14	1.56±0.13	.006*
ICAM-1 (ng/mL)	14.54±1.21	13.75±1.24	.048*	13.16±1.10	13.10±1.09	.528
VCAM-1 (ng/mL)	74.33±6.27	72.21±6.15	.454	54.39±4.76	54.10±4.39	.564

CAD: coronary artery disease;*: significant; SD: standard deviation; IL: interleukin; ng: nanogram; pg: pikogram; mL: mililiter; IFN: interferon; ICAM: Intercellular adhesion molecule; VCAM: vascular adhesion molecule; IgA: immunoglobulin A; +ve: positive; −ve: negative.